ReviewInfectious diseases and therapy2020

Bezlotoxumab for Preventing Recurrent Clostridioides difficile Infection: A Narrative Review from Pathophysiology to Clinical Studies.

Daniele Roberto Giacobbe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.